← Back to all trials
Recruiting
NCT05611762
Narrow-band Imaging Diagnostic Classification System for Bladder Tumors
Conditions: Urinary Bladder Neoplasms
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: 1
Enrollment: 1064
Sponsor: Qilu Hospital of Shandong University (Qingdao)
Location: China
Summary
The goal of this observational study is to learn about the morphological characteristics of different bladder lesions under narrow-band imaging(NBI) techniques in All patients requiring cystoscopy and biopsy.
The main questions it aims to answer are:To clarify the characteristics of different bladder lesions under NBI and to establish a diagnostic classification system for bladder tumors under NBI based on pathological findings.Verify the accuracy of this classification system.
Participants will record the morphological characteristics under ordinary white light and NBI during cystoscopy, analyze the pathological characteristics of different tissues corresponding to the NBI characteristics, establish a diagnostic classification system for bladder tumor under NBI using pathological biopsy as the diagnostic standard, and then verify the accuracy of this classification standard through clinical.
Eligibility Criteria
Inclusion Criteria:Age between 18 and 75 years old.Patients who require cystoscopy for definitive diagnosis due to hematuria or bladder occupancy; or patients who are routinely reviewed by cystoscopy after electrodesiccation of urinary bladder tumor (TURBT).Subjects were able to understand the study content and sign the informed consent form, and were able to actively cooperate and follow the study procedures.Exclusion Criteria:People with coagulation disorders.Combined with acute urinary tract infection or postoperative infusion of BCG vaccine.Urethral stricture or bladder volume too small to perform cystoscopy.Severe cardiopulmonary dysfunction who cannot tolerate local anesthesia surgery.Women who are menstruating or more than 3 months pregnant.
Source: ClinicalTrials.gov (NCT05611762). StuddyBuddy aggregates publicly available trial information.